Jill Ann Howe Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity
Jill Ann Howe is Chief Financial Officer of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 10,500 shares of LCTX, which is worth approximately $6,720. The most recent transaction as insider was on Aug 16, 2024, when has been sold 10,500 shares (Common Shares) at a price of $0.89 per share, resulting in proceeds of $9,345. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10.5K
0%
3M change
n/a
12M change
Total Value Held
$6,720
Jill Ann Howe Transaction History
Also insider at
JAH
Jill Ann Howe
Chief Financial Officer
San Diego, CA